Detalhe da pesquisa
1.
Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study.
Digestion
; 104(4): 283-290, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36716726
2.
Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study.
Esophagus
; 18(3): 669-675, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33221955
3.
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases.
J Gastroenterol Hepatol
; 35(8): 1412-1419, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31896166
4.
The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.
J Med Virol
; 91(4): 650-658, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30381831
5.
Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Esophagus
; 16(2): 141-146, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30173282
6.
Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
Int J Cancer
; 142(7): 1418-1426, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29134647
7.
Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure.
J Gen Virol
; 99(8): 1058-1065, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29916799
8.
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice.
Biochem Biophys Res Commun
; 500(2): 152-157, 2018 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29621544
9.
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients.
J Viral Hepat
; 25(12): 1555-1564, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29998562
10.
Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C.
J Med Virol
; 90(12): 1834-1840, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30016555
11.
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.
Hepatol Res
; 48(1): 51-58, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28342265
12.
Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosis.
Hepatol Res
; 48(4): 264-274, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29114970
13.
Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Antimicrob Agents Chemother
; 61(6)2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28373196
14.
Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized Mice.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28696237
15.
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
J Gen Virol
; 98(5): 1040-1047, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28141486
16.
Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.
J Med Virol
; 89(4): 665-671, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27602542
17.
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.
J Med Virol
; 89(11): 1963-1972, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28657143
18.
H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters.
J Biomed Sci
; 24(1): 91, 2017 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29202755
19.
IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C.
Hepatol Res
; 47(3): E5-E13, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27027531
20.
Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection.
Hepatol Res
; 47(8): 767-772, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-27591427